Overview
Top Medical Research Studies
The research revealed that insufficient vitamin D led to a drop in Sirt1, a gene that plays a crucial role in maintaining bone density. This lack of Sirt1 resulted in increased bone loss. However, when we boosted Sirt1 levels in bone stem cells, we observed a reversal in bone loss. This improvement happened because higher Sirt1 levels reduced oxidative stress, slowed down aging processes in bone cells, and enhanced new bone formation while curbing bone resorption.
Additionally, our findings indicated that vitamin D directly stimulates Sirt1 expression in these stem cells, which is vital for bone health. We also explored the effects of resveratrol, a natural compound known for activating Sirt1, and found it helped alleviate osteoporosis symptoms linked to vitamin D deficiency by enhancing the relationship between Sirt1 and another protein called PGC1α, which supports bone formation and energy metabolism.
This research underscores the importance of the vitamin D-Sirt1/PGC1α axis in bone metabolism, providing insight into how vitamin D can serve as a target for osteoporosis prevention and treatment.
Current literature indicates that taking high doses of vitamin D intermittently, such as 60,000 IU a month, can actually elevate the chances of falls, fractures, and even premature death in some groups. Conversely, daily supplementation of 800-1000 IU, particularly alongside calcium, has been shown to reduce falls and non-vertebral fractures in the elderly who have a vitamin D deficiency.
Before anyone starts supplementing, it is crucial to measure their vitamin D levels to achieve a target concentration of 30 to 60 ng/mL. For those needing a quick boost in vitamin D levels—like patients showing symptoms of osteomalacia or those with critically low vitamin D—a starting loading dose followed by daily maintenance is the preferred approach. If daily options aren’t available, of course, a smaller intermittent dose can be a temporary solution until better options are accessible.
Our study demonstrated that treating the mice with FSHHK13M1 led to a significant increase in their serum levels of active vitamin D metabolites, particularly 1,25-dihydroxy vitamin D. This increase was linked to activation of important bone health pathways, helping to fortify bone structure and function.
Not only did we observe improvements in vitamin D levels, but the intervention also restored balance in the gut microbiota, which showed signs of imbalance in mice suffering from osteoporosis. The findings suggest that FSHHK13M1 could be a promising direction for improving bone health and reducing fracture risks in the elderly by enhancing vitamin D levels naturally.
Overall, this research highlights the potential of combining probiotics with vitamin D strategies for better management of osteoporosis, especially in older populations who often face challenges absorbing conventional treatments.
Most Useful Reviews
Medical Researches
- All Researches
Our focus on this case revealed that vitamin D3 played an essential role in supporting the patient’s bone health. This addition helped mitigate some side effects of long-term steroid use, specifically protecting against osteoporosis, while the patient experienced significant improvements in their orbital symptoms.
Over the course of treatment, the patient showed remarkable recovery in just 24 hours, along with a complete resolution of issues related to their eye condition over the following year. While direct data on vitamin D3's standalone effectiveness isn't highlighted, its use in this context underscores a possible beneficial role in osteoporosis prevention when combined with corticosteroids.
Our study demonstrated that treating the mice with FSHHK13M1 led to a significant increase in their serum levels of active vitamin D metabolites, particularly 1,25-dihydroxy vitamin D. This increase was linked to activation of important bone health pathways, helping to fortify bone structure and function.
Not only did we observe improvements in vitamin D levels, but the intervention also restored balance in the gut microbiota, which showed signs of imbalance in mice suffering from osteoporosis. The findings suggest that FSHHK13M1 could be a promising direction for improving bone health and reducing fracture risks in the elderly by enhancing vitamin D levels naturally.
Overall, this research highlights the potential of combining probiotics with vitamin D strategies for better management of osteoporosis, especially in older populations who often face challenges absorbing conventional treatments.
One standout example is a derivative known as AH-1, which demonstrated significant benefits for bone health in an osteoporosis model using ovariectomized rats. When given at a low dosage, AH-1 outperformed natural vitamin D, suggesting a promising path for improving osteoporosis treatment.
We also noted that while traditional vitamin D has its benefits, these newly developed analogs could lead to treatments that target osteoporosis more effectively, providing options without the side effects commonly associated with vitamin D therapy. This research emphasizes the importance of vitamin D derivatives as we seek better solutions for managing bone health.
The research involved categorizing 28 rats into four groups, with one group receiving just anastrozole, while the other groups were treated with either selenium nanoparticles or Nano Vitamin D3 alongside anastrozole. After four weeks of treatment, we looked closely at the rats' mandibular bones to see how these treatments affected bone health.
Our findings indicated that both Selenium nanoparticles and Nano Vitamin D3 showed improvements in bone structure and cell health compared to the animals taking only anastrozole. The rats in the treatment groups demonstrated more newly formed collagen and healthier osteoblasts—cells that play a crucial role in bone formation. While we focused heavily on comparing these two approaches to therapy, the results confirmed that using Nano Vitamin D3 can be beneficial for combating osteoporosis exacerbated by anastrozole.
After the children reached ages 6 to 7, we assessed their bone health using advanced scanning techniques. The results revealed that those children whose mothers had received vitamin D3 supplementation exhibited higher BMD compared to those whose mothers received the placebo. This suggests that supplementing pregnant women with vitamin D3 could be a valuable public health strategy for improving bone health in children.
Even though this study focused on childhood, it reflects broader implications for how vitamin D3 might help in preventing conditions like osteoporosis later in life.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Osteoporosis is a medical condition characterized by weakened bones, making them fragile and more prone to fractures. This condition occurs when the body loses too much bone mass, doesn't make enough bone, or a combination of both. As bones lose density, they can break more easily, often as a result of minor falls or injury. Osteoporosis is often referred to as a "silent disease" because bone loss occurs without any symptoms until a fracture occurs, often in the hip, spine, or wrist.
Risk factors for developing osteoporosis include age, gender (it’s more common in women), family history, low body weight, and certain medical conditions and medications. Lifestyle choices such as smoking, excessive alcohol consumption, and a diet low in calcium and vitamin D can also contribute to bone loss. Regular weight-bearing exercise, ensuring adequate nutrition, and, in some cases, medications can help prevent or manage osteoporosis. If you believe you may be at risk, it is important to consult with a healthcare professional for appropriate screening and intervention options.
Vitamin D is a fat-soluble vitamin that's essential for maintaining healthy bones and teeth, supporting immune system function, and facilitating normal cell growth and development. It plays a crucial role in calcium absorption in the gut, which is vital for bone health. Unlike most vitamins, our bodies can produce Vitamin D when exposed to sunlight, specifically UVB rays, which is why it’s often referred to as the "sunshine vitamin." However, depending on your geographical location, lifestyle, and skin type, getting sufficient Vitamin D from the sun alone can be challenging, particularly during the winter months.
In addition to sunlight, Vitamin D can be obtained from certain foods such as fatty fish (like salmon and mackerel), fish liver oils, and fortified foods like milk and cereals. Some individuals may also consider supplements, especially if they're at risk for deficiency. Insufficient vitamin D levels are linked to various health issues, including rickets in children, osteomalacia in adults, and even an increased risk of chronic diseases. Regularly checking your vitamin D levels and consulting with a healthcare professional can help ensure you're meeting your needs for optimal health.
Vitamin D plays a crucial role in bone health, and its connection to osteoporosis is well-documented. Osteoporosis is a condition characterized by weak and brittle bones, making individuals more susceptible to fractures. Adequate levels of vitamin D are essential for the body to absorb calcium, which is vital for maintaining bone density and strength. When vitamin D levels are low, the body cannot effectively use calcium, potentially leading to a decrease in bone mass and an increased risk of osteoporosis.
Several studies have shown that vitamin D supplementation can have a positive impact on bone health, particularly in older adults who are more prone to osteoporosis. While vitamin D alone is not a standalone treatment for osteoporosis, it is typically recommended alongside calcium and other lifestyle changes, such as weight-bearing exercise, to help mitigate the risk of bone loss. If you are concerned about osteoporosis or your vitamin D levels, it’s advisable to consult with a healthcare professional who can provide personalized recommendations based on your specific needs and health status.
Based on user reviews, the timeline for seeing results when taking Vitamin D supplements for osteoporosis can vary considerably. Many users note that those with severe Vitamin D deficiencies may experience immediate benefits upon starting the supplement, as it significantly aids in improving bone strength and absorption of calcium, which is crucial for preventing osteoporosis (Read Review). Others have cited the importance of long-term use, indicating that consistent weekly intake is key to maintaining adequate Vitamin D levels and overall bone health. Users typically recommend a duration of several weeks to months to fully appreciate the enhancement in bone strength and immunity provided by Vitamin D (Read Review).
It's important to note that while individual results may differ, users generally agree on the need for continual supplementation to effectively address osteoporosis. Some report a gradual improvement in bone strength and reduction in symptoms, emphasizing the long-term commitment to taking the supplement as per recommended dosages (Read Review). Thus, while initial results may be noted relatively quickly for those deficient in Vitamin D, sustained use is crucial for lasting benefits.
The evidence supporting the use of Vitamin D as a supplement for managing osteoporosis is significant, although some studies indicate that further research is needed for conclusive results. For instance, research highlights that vitamin D plays a key role in maintaining bone density, especially among individuals at risk of osteoporosis, such as older adults and those undergoing other treatments like chemotherapy or glucocorticoids ([1], [2], [4]). Daily supplementation, specifically at doses ranging from 800 to 1000 IU, has shown positive outcomes in reducing falls and fractures, critical components in the management of osteoporosis ([4]). Nevertheless, caution is warranted as high doses of vitamin D administered intermittently may raise the risk of adverse events, such as fractures and falls ([4]).
In addition to vitamin D, there appears to be a synergistic effect when combined with calcium or other interventions, like probiotics or medications such as raloxifene. These combinations have demonstrated notable improvements in bone density and overall bone health ([13]). The vitamin D-related pathways, particularly involving proteins like Sirt1, are essential in this context, as they help regulate bone metabolism and strengthen bone mass ([12]). However, while these findings indicate a promising role for vitamin D in osteoporosis treatment, individual responses can vary widely, emphasizing the importance of personalized treatment plans guided by healthcare professionals.
Based on user reviews, many individuals have reported significant improvements in their symptoms related to bone health and osteoporosis after incorporating Vitamin D supplements into their routines. Users often highlight that an adequate intake of Vitamin D enhances calcium absorption, which is vital for fostering bone strength and preventing osteoporosis-related fractures. One reviewer noted that this particular product is crucial for those with severe Vitamin D deficiency, providing immediate results in strengthening bones and improving immunity (Read Review). Another user emphasized the importance of maintaining proper Vitamin D levels to ensure overall health and skin integrity, further supporting its role in bone health (Read Review).
Users also reported benefits beyond bone strength, such as enhanced resistance to infections and support for recovery from various health issues. Several reviews underline the need for regular supplementation, with some users taking high doses to adequately address deficiencies and improve their overall well-being (Read Review). While experiences can vary widely, the general consensus indicates that those incorporating Vitamin D supplements report positive effects on their health, particularly in relation to osteoporosis prevention (Read Review).
Users have reported that combining Vitamin D supplementation with other nutrients plays a significant role in managing osteoporosis effectively. Many emphasize the importance of Vitamin D for calcium absorption, which is critical in strengthening bones and preventing osteoporosis-related fractures (Read Review). Reviewers have suggested that taking Vitamin D with a fatty meal enhances its efficacy, which can lead to greater overall bone health and strength (Read Review).
Additionally, some users have taken high doses of Vitamin D alongside other supplements, such as magnesium and calcium, to optimize their bone health and mitigate osteoporosis risks further. For instance, one reviewer mentioned the need for significant weekly dosages, which they attributed to their efforts to combat deficiencies effectively (Read Review). This strategy appears to be particularly beneficial for those undergoing treatments that may affect bone density, reflecting a customized approach to supplementation that receives positive user feedback (Read Review).
According to recent research, the optimal dosage of Vitamin D for treating osteoporosis ranges from 800 to 1000 IU (International Units) per day. This range has been shown to be effective in improving bone health and reducing the risk of falls and fractures, particularly among older adults who are often at a higher risk for vitamin D deficiency [4]. Furthermore, before starting supplementation, it’s important to assess individual vitamin D levels to ensure they are aiming for a target concentration of 30 to 60 ng/mL, which supports better bone density [4].
Additionally, while daily dosages of 800-1000 IU are generally safe, concerns arise over the use of higher intermittent doses, such as 60,000 IU monthly, which could increase the risk of falls and other complications [4]. When considering Vitamin D supplementation for osteoporosis management, incorporating regular monitoring and consultation with a healthcare provider can help tailor the approach to individual needs, ultimately enhancing bone health effectively.
Our findings indicated that adequate levels of VD are important for maintaining bone density in patients, especially those receiving preoperative chemoradiotherapy. Some studies showed that vitamin D supplementation could lessen certain severe side effects, like fatigue and nausea, often experienced during cancer treatments.
However, the evidence regarding the isolated effects of vitamin D on osteoporosis, specifically, was limited due to the varied designs of the included studies. Despite these challenges, it seems clear that vitamin D plays a valuable role in managing bone health and reducing treatment-related complications.
Our study demonstrated that treating the mice with FSHHK13M1 led to a significant increase in their serum levels of active vitamin D metabolites, particularly 1,25-dihydroxy vitamin D. This increase was linked to activation of important bone health pathways, helping to fortify bone structure and function.
Not only did we observe improvements in vitamin D levels, but the intervention also restored balance in the gut microbiota, which showed signs of imbalance in mice suffering from osteoporosis. The findings suggest that FSHHK13M1 could be a promising direction for improving bone health and reducing fracture risks in the elderly by enhancing vitamin D levels naturally.
Overall, this research highlights the potential of combining probiotics with vitamin D strategies for better management of osteoporosis, especially in older populations who often face challenges absorbing conventional treatments.
Current literature indicates that taking high doses of vitamin D intermittently, such as 60,000 IU a month, can actually elevate the chances of falls, fractures, and even premature death in some groups. Conversely, daily supplementation of 800-1000 IU, particularly alongside calcium, has been shown to reduce falls and non-vertebral fractures in the elderly who have a vitamin D deficiency.
Before anyone starts supplementing, it is crucial to measure their vitamin D levels to achieve a target concentration of 30 to 60 ng/mL. For those needing a quick boost in vitamin D levels—like patients showing symptoms of osteomalacia or those with critically low vitamin D—a starting loading dose followed by daily maintenance is the preferred approach. If daily options aren’t available, of course, a smaller intermittent dose can be a temporary solution until better options are accessible.
When we analyzed the results, we observed that while the supplementation of vitamin D3 was part of the treatment protocol, the primary focus remained on comparing the effectiveness and safety of the two forms of denosumab. The outcomes mainly centered on improvements in bone density at specific sites, such as the lumbar spine and femur neck. However, the benefits directly attributable to vitamin D3 supplementation were not distinctly isolated in this study's findings.
Overall, the findings revealed that the biosimilar denosumab was just as effective as the reference drug in managing osteoporosis, offering a potentially more affordable treatment option for patients. While vitamin D3 is essential for bone health, the significance of its individual role in this study is less clear, as the primary benefits were linked more to the denosumab treatments.
Our findings revealed that a deficiency in active vitamin D, or 1,25-dihydroxyvitamin D, led to decreased levels of an important protein called Sirt1, which is crucial for bone health. This drop in Sirt1 resulted in accelerated bone loss. Encouragingly, we discovered that overexpressing Sirt1 in mesenchymal stem cells could actually reverse this bone loss. It achieved this by reducing oxidative stress and promoting healthy bone formation while minimizing bone resorption.
Additionally, our study showed that vitamin D3 boosts Sirt1 levels through a direct interaction with its gene promoter. This means that adequate vitamin D not only supports Sirt1 levels but also plays a key role in regulating its activity in bone cells. We also examined the effects of resveratrol, a compound that activates Sirt1, and found it could mitigate the negative impact of vitamin D insufficiency on bone health.
Overall, we observed that the vitamin D-Sirt1/PGC1α axis is vital for maintaining bone health, especially when vitamin D levels are insufficient. These insights highlight the potential for targeting this pathway as a promising strategy for preventing and treating osteoporosis.
References
- Afonso ML, Capelas ML, Pimenta NM, Santos T, Mäkitie A, et al. A Systematic Review of Vitamin D Supplementation in Oncology: Chance of Science or Effectiveness?. Nutrients. 2025;17. doi:10.3390/nu17040634
- Wang H, Tian G, Pei Z, Yu X, Wang Y, et al. increases serum vitamin D metabolite levels and modulates intestinal flora to alleviate osteoporosis in mice. mSphere. 2025. doi:10.1128/msphere.01039-24
- Skubica P, Hoffmanova I, Dankova P. Chronically increased osteoclastogenesis in adult celiac disease patients does not hinder improvement in bone health induced by gluten-free diet: Role of vitamin D, OPG and IL-6. J Nutr Biochem. 2025. doi:10.1016/j.jnutbio.2025.109871
- Pickering ME, Souberbielle JC, Boutten A, Breuil V, Briot K, et al. Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO. Joint Bone Spine. 2025;92:105858. doi:10.1016/j.jbspin.2025.105858
- Shi L, Bao Y, Deng X, Xu X, Hu J. Association between calcium and vitamin D supplementation and increased risk of kidney stone formation in patients with osteoporosis in Southwest China: a cross-sectional study. BMJ Open. 2025;15:e092901. doi:10.1136/bmjopen-2024-092901
- Zhang SB, Yang J, Xu HW, Yi YY, Ren CX, et al. Association Between 25-hydroxyvitamin D Status and New Vertebral Fractures Post Percutaneous Vertebral Augmentation in Patients During Postmenopause: A Retrospective Case-control Study. Pain Physician. 2025;28:E31.
- Yang C, Chen L, Guo X, Sun H, Miao D. The Vitamin D-Sirt1/PGC1α Axis Regulates Bone Metabolism and Counteracts Osteoporosis. J Orthop Translat. 2025;50:211. doi:10.1016/j.jot.2024.10.011
- Kuwabara N, Kanda J, Sato S, Nakagawa S. Impact of Daily High Ergosterol Intake for 14 Weeks in Ovariectomized Rats on Cholesterol and Vitamin D Biosynthesis Pathways. Biol Pharm Bull. 2025;48:39. doi:10.1248/bpb.b24-00536
- McCarrison S, Abdelrahman S, Quinlivan R, Keen R, Wong SC. Pharmacological and non-pharmacological therapies for prevention and treatment of osteoporosis in Duchenne Muscular Dystrophy: A systematic review. Bone. 2025;193:117410. doi:10.1016/j.bone.2025.117410
- Ma M, Zhang Y, Liu J, Tian C, Duan Z, et al. Associations of the serum 25-hydroxyvitamin D with mortality among patients in osteopenia or osteoporosis. Bone. 2025. doi:10.1016/j.bone.2025.117408
- Mendoza-Vargas LÁ, Sevilla-Fuentes S, Bautista-Becerril B, Berthaúd-González B, Falfán-Valencia R, et al. IgG4-RD-Associated Mikulicz Syndrome Without Classic Systemic Involvement-A Case Report. J Clin Med. 2025;14. doi:10.3390/jcm14030958
- Yang C, Chen L, Guo X, Sun H, Miao D. The Vitamin D-Sirt1/PGC1α Axis Regulates Bone Metabolism and Counteracts Osteoporosis. J Orthop Translat. 2025;50:211. doi:10.1016/j.jot.2024.10.011
- Paul T, Garg B, Kapoor N, Patil V, Kachnerkar N, et al. A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis. J Assoc Physicians India. 2025;73:e8. doi:10.59556/japi.73.0772
- Sawant D, Kamble N. Overcoming Recurrent Isolated Sleep Paralysis: A Case Report of Integrative Management With Yoga, Meditation, and Vitamin D3 Supplementation. Cureus. 2024;16:e76626. doi:10.7759/cureus.76626
- Kittaka A. Synthetic Studies on Vitamin D Derivatives with Diverse but Selective Biological Activities. Chem Pharm Bull (Tokyo). 2025;73:1. doi:10.1248/cpb.c24-00598
- Elmalah SG, Mohsen ROM, Hassan R. Selenium nano particles versus nano vitamin D3 in modulating anastrozole-induced osteoporosis on the mandibular alveolar bone of albino rats. J Stomatol Oral Maxillofac Surg. 2024. doi:10.1016/j.jormas.2024.102181
- Chang CH, Yang SJ, Young TH, Yao WC. Effect of co-loaded vitamin D3 on intravenous injectable raloxifene delivery system. Colloids Surf B Biointerfaces. 2025;246:114379. doi:10.1016/j.colsurfb.2024.114379
- Kluijver LG, Wagenmakers MAEM, Wilson JHP, Langendonk JG. The impact of minimal sunlight exposure on bone health: insights from a cohort study in erythropoietic protoporphyria. J Clin Endocrinol Metab. 2024. doi:10.1210/clinem/dgae729
- Chen Y, Qiu H, Xuan L, Jin Y, Chen R, et al. Acupuncture in Treating Osteopenia: A Multicenter, Randomized, Controlled Clinical Trial. Complement Med Res. 2024;31:516. doi:10.1159/000541440
- Moon RJ, D' Angelo S, Curtis EM, Ward KA, Crozier SR, et al. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. Am J Clin Nutr. 2024;120:1134. doi:10.1016/j.ajcnut.2024.09.014
- Pinto-Bonilla R, Baeza-Noci J, Blanco CC, Gumbau GJV, Fernández RJ, et al. Real-world effectiveness and safety of combined calcium 600 mg and cholecalciferol 2000 IU for treating vitamin d deficiency: Results from a nationwide study with focus in osteoporosis. Bone Rep. 2024;22:101796. doi:10.1016/j.bonr.2024.101796
- Xu D, Liu J, Zhang D, Zhang X, Huang C, et al. [Effects of thunder-fire moxibustion on balance function and musculoskeletal metabolism in female patients of primary osteoporosis with low muscle mass]. Zhongguo Zhen Jiu. 2024;44:859. doi:10.13703/j.0255-2930.20231229-0002
- Shin S, Hong N, Rhee Y. A randomized controlled trial of the effect of raloxifene plus cholecalciferol versus cholecalciferol alone on bone mineral density in postmenopausal women with osteopenia. JBMR Plus. 2024;8:ziae073. doi:10.1093/jbmrpl/ziae073
- Wu T, Lin Z, Wang C, Liu X. Correlation between vitamin D levels and blood pressure in elderly hypertensive patients with osteoporosis. Front Med (Lausanne). 2024;11:1396254. doi:10.3389/fmed.2024.1396254
